Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Scot Niglio"'
Autor:
Ravi Madan, Seth Steinberg, Jung-Min Lee, Marijo Bilusic, Fatima Karzai, Houssein Abdul Sater, Scot Niglio, Jason Redman, Charalampos Floudas, Andrea Apolo
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/8f92d05cc5474115bdc78a704b5e3f5b
Autor:
Talal El Zarif, Amin Nassar, Gregory R. Pond, Tony Zibo Zhuang, Viraj A. Master, Bassel Nazha, Scot Niglio, Nicholas Simon, Andrew W. Hahn, Curtis A. Pettaway, Shi-Ming Tu, Noha Abdel-Wahab, Maud Velev, Ronan Flippot, Sebastiano Buti, Marco Maruzzo, Arjun Mittra, Jinesh Gheeya, Yuanquan Yang, Pablo Alvarez Rodriguez, Daniel Castellano, Guillermo de Velasco, Giandomenico Roviello, Lorenzo Antonuzzo, Rana R. McKay, Bruno Vincenzi, Alessio Cortellini, Gavin Hui, Alexandra Drakaki, Michael Glover, Ali Raza Khaki, Edward El-Am, Nabil Adra, Tarek H. Mouhieddine, Vaibhav Patel, Aida Piedra Cascon, Angela Gernone, Nancy B. Davis, Harrison Matthews, Michael R. Harrison, Ravindran Kanesvaran, Giulia Claire Giudice, Pedro Barata, Alberto Farolfi, Jae Lyun Lee, Matthew I. Milowsky, Charlotte Stahlfeld, Leonard Appleman, Joseph Kim, Dory Freeman, Toni K. Choueiri, Philippe E. Spiess, Andrea Necchi, Andrea Apolo, Guru P. Sonpavde
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e28fdcfe0617f6bf8878a9f770d7ffdd
https://doi.org/10.2139/ssrn.4404850
https://doi.org/10.2139/ssrn.4404850
Autor:
Andrea B. Apolo, Pavlos Msaouel, Scot Niglio, Nicholas Simon, Elias Chandran, Deborah Maskens, Gabriela Perez, Karla V. Ballman, Chana Weinstock
Publikováno v:
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 42
The role of adjuvant therapy in renal cell carcinoma and urothelial carcinoma is rapidly evolving. To date, the U.S. Food and Drug Administration has approved sunitinib and pembrolizumab in the adjuvant setting for renal cell carcinoma and nivolumab
Autor:
Alessandro Laganà, Itai Beno, David Melnekoff, Violetta Leshchenko, Deepu Madduri, Dennis Ramdas, Larysa Sanchez, Scot Niglio, Deepak Perumal, Brian A. Kidd, Riccardo Miotto, Jane Houldsworth, Rita Shaknovich, Ajai Chari, Hearn Jay Cho, Bart Barlogie, Sundar Jagannath, Joel T. Dudley, Samir Parekh
Publikováno v:
JCO precision oncology
Purpose Multiple myeloma (MM) is a malignancy of plasma cells, with a median survival of 6 years. Despite recent therapeutic advancements, relapse remains mostly inevitable, and the disease is fatal in the majority of patients. A major challenge in t